Medicare Test Co-Pays Would Add To Labs’ Overhead; Firms Brace For Impact
This article was originally published in The Gray Sheet
Executive Summary
Diagnostic testing firms' profitability could suffer along with patient access to care if a laboratory diagnostic co-payment provision is included in pending Medicare reform legislation, stakeholders say